当前位置:首页 - 行情中心 - 奥泰生物(688606) - 财务分析 - 现金流量表

奥泰生物

(688606)

  

流通市值:39.39亿  总市值:39.39亿
流通股本:7928.09万   总股本:7928.09万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金200,842,985.18890,215,461.66603,168,086.39406,781,612.87
  收到的税费返还5,110.3426,112,577.4326,364,742.6522,560,355.25
  收到其他与经营活动有关的现金2,743,596.9553,240,394.7842,242,732.7321,636,906.42
  经营活动现金流入小计203,591,692.47969,568,433.87671,775,561.77450,978,874.54
  购买商品、接受劳务支付的现金137,837,749.72412,946,825.5271,454,439.49196,560,468.32
  支付给职工以及为职工支付的现金54,791,709.71176,837,435.28146,583,141.2890,667,788.36
  支付的各项税费20,215,209.5553,772,413.6229,385,705.7423,025,629.44
  支付其他与经营活动有关的现金22,928,850.54119,418,769.09109,892,673.2779,371,352.67
  经营活动现金流出小计235,773,519.52762,975,443.49557,315,959.78389,625,238.79
  经营活动产生的现金流量净额-32,181,827.05206,592,990.38114,459,601.9961,353,635.75
二、投资活动产生的现金流量:
  收回投资收到的现金986,714,788.522,077,271,833.571,625,959,726.121,323,366,810.53
  取得投资收益收到的现金726,239.243,209,102.479,159,557.797,053,526.66
  处置固定资产、无形资产和其他长期资产收回的现金净额212,009.21685,480.186,866,995.119,799,934.04
  收到的其他与投资活动有关的现金-20,000,00020,000,000-
  投资活动现金流入小计987,653,036.972,101,166,416.221,661,986,279.021,340,220,271.23
  购建固定资产、无形资产和其他长期资产支付的现金22,621,459.18219,096,818.43158,771,492.08120,754,290.25
  投资支付的现金151,428,156.531,732,106,273.631,423,303,120.96973,386,622.12
  支付其他与投资活动有关的现金-4,288,980--
  投资活动现金流出小计174,049,615.711,955,492,072.061,582,074,613.041,094,140,912.37
  投资活动产生的现金流量净额813,603,421.26145,674,344.1679,911,665.98246,079,358.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金---3,396.29
  其中:子公司吸收少数股东投资收到的现金---3,396.29
  收到其他与筹资活动有关的现金286,068.7820,003,703.7710,357,453.01-
  筹资活动现金流入小计286,068.7820,003,703.7710,357,453.013,396.29
  分配股利、利润或偿付利息支付的现金-195,109,725116,798,446.33116,801,088.61
  支付其他与筹资活动有关的现金86,152,015.462,898,998.051,878,977.471,342,278.99
  筹资活动现金流出小计86,152,015.46198,008,723.05118,677,423.8118,143,367.6
  筹资活动产生的现金流量净额-85,865,946.68-178,005,019.28-108,319,970.79-118,139,971.31
四、汇率变动对现金及现金等价物的影响-14,518,117.23-11,836,543.94-5,492,523.53-630,750.5
五、现金及现金等价物净增加额681,037,530.3162,425,771.3280,558,773.65188,662,272.8
  加:期初现金及现金等价物余额1,066,980,006.91900,336,955.59900,336,955.59900,336,955.59
  期末现金及现金等价物余额1,748,017,537.211,062,762,726.91980,895,729.241,088,999,228.39
补充资料:
  净利润-220,071,907.4-132,101,804.86
  资产减值准备-4,261,937.03-608,005.17
  固定资产和投资性房地产折旧-38,026,228.51-14,984,686.14
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-38,026,228.51-14,984,686.14
  无形资产摊销-1,508,573.62-695,669.45
  长期待摊费用摊销-5,880,108.09-3,381,437.94
  处置固定资产、无形资产和其他长期资产的损失--616,679.63--
  固定资产报废损失-21,655.21-2,712.14
  公允价值变动损失--40,611,636.15--15,823,882.7
  财务费用-9,422,355.94-108,215.33
  投资损失--335,646.32--6,084,326.45
  递延所得税-143,986.42--3,083,990.79
  其中:递延所得税资产减少-155,260.53--3,072,716.68
    递延所得税负债增加--11,274.11--11,274.11
  存货的减少--20,551,674.03--6,893,892.49
  经营性应收项目的减少--77,629,154.9--40,221,876.2
  经营性应付项目的增加-42,706,748.76--32,616,589.87
  其他-18,510,834.19-9,199,135.78
  不涉及现金收支的投资和筹资活动金额其他项目-8,290,714.62--
  现金的期末余额-1,062,762,726.91-1,088,999,228.39
  减:现金的期初余额-900,336,955.59-900,336,955.59
  现金及现金等价物的净增加额-162,425,771.32-188,662,272.8
公告日期2026-04-202026-04-202025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑